Dáil Éireann Debate, Tuesday - 21 March 2023
1238. Deputy Paul Kehoe asked the Minister for Health if he will provide an update on the position of access to Kaftrio for the 35 excluded children with cystic fibrosis; and if he will make a statement on the matter. [12596/23]
View answer1375. Deputy James Browne asked the Minister for Health the position regarding the outcome of recent meetings with the HSE and a company regarding securing the drug Kaftrio for children with cystic fibrosis; and if he will make a statement on the matter. [13175/23]
View answerI propose to take Questions Nos. 1238 and 1375 together.
The Health Technology Assessment was received by the HSE from the NCPE on February 9, 2023. The discussions between the HSE and Vertex Pharmaceuticals are at a sensitive stage, and the Minister is not in a position to make any comment at this time.
